SOPHiA GENETICS (SOPH) CFO George Cardoza Sells 774 Shares

What Happened George Cardoza, Chief Financial Officer of SOPHiA GENETICS SA (SOPH), sold 774 shares in an open-market transaction on March 19, 2026. The weighted average price reported was $4.79 (range $4.72–$4.87), for total proceeds of about $3,705. The sale was made to satisfy tax withholding obligations from the vesting of restricted stock units on March 18, 2026 and was executed under a pre-established Rule 10b5-1 trading plan (non-discretionary).

Key Details

• Transaction date: 2026-03-19
• Shares sold: 774; weighted average price $4.79; price range $4.72–$4.87
• Proceeds: approximately $3,705
• Reason/footnote: sale to satisfy RSU tax withholding (F1); executed pursuant to a pre-established 10b5-1 plan and not a discretionary trade
• Pricing note (F2): reported price is a weighted average; the filer can provide per-trade prices on request
• Shares owned after transaction: not stated in the provided filing
• Filing timeliness: filed 2026-03-20 for a 2026-03-19 transaction (appears timely)

Context This was a routine tax-withholding sale tied to RSU vesting, not an open discretionary sell signal. Sales executed under 10b5-1 plans are pre-planned and often reflect administrative needs (taxes or liquidity) rather than a change in an insider’s view of the company. Purchases typically carry more weight for signaling insider confidence.